• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

怀孕会降低新冠疫苗对新型变体的免疫力。

Pregnancy reduces COVID-19 vaccine immunity against novel variants.

作者信息

Parish Maclaine A, Sachithanandham Jaiprasath, Gutierrez Lizeth, Park Han-Sol, Yin Anna, Roznik Katerina, Creisher Patrick, Lee John S, St Clair Laura A, Werner Annie, Pilgrim-Grayson Catherine, Berhane Lea, Golding Hana, Shea Patrick, Fenstermacher Katherine, Rothman Richard, Burd Irina, Sheffield Jeanne, Cox Andrea L, Pekosz Andrew, Klein Sabra L

机构信息

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

NPJ Vaccines. 2025 Aug 13;10(1):191. doi: 10.1038/s41541-025-01236-4.

DOI:10.1038/s41541-025-01236-4
PMID:40804265
Abstract

Pregnant women are at heightened risk for severe outcomes from infectious diseases like COVID-19, yet were not included in initial vaccine trials, which may contribute to low booster uptake (15% or lower). We explored the serological and cellular responses to COVID-19 mRNA booster vaccines (i.e., ancestral and BA.5) in pregnant and age-matched, non-pregnant females to identify how pregnancy affects immunity against the vaccine and novel variants. Antibodies from pregnant women were less cross-reactive to non-vaccine antigens, including XBB.1.5 and JN.1. Non-pregnant females showed greater IgG1:IgG3 ratios and neutralization against all variants. In contrast, pregnant women had lower IgG1:IgG3 ratios and neutralization but increased antibody-dependent NK cell cytokine production and neutrophil phagocytosis, especially against novel variants. Pregnancy increased memory CD4+ T cells, IFNγ production, monofunctional dominance, and fatty acid oxidation. Pregnancy may reduce the breadth, composition, and magnitude of humoral and cellular immunity, particularly in response to novel variants.

摘要

孕妇感染新冠病毒等传染病后出现严重后果的风险更高,但她们未被纳入最初的疫苗试验,这可能导致加强针接种率较低(15%或更低)。我们研究了孕妇和年龄匹配的非孕妇对新冠病毒mRNA加强疫苗(即原始毒株和BA.5)的血清学和细胞反应,以确定怀孕如何影响对疫苗和新变种的免疫力。孕妇的抗体与非疫苗抗原(包括XBB.1.5和JN.1)的交叉反应性较低。非孕妇的IgG1:IgG3比值更高,对所有变种的中和作用更强。相比之下,孕妇的IgG1:IgG3比值和中和作用较低,但抗体依赖性NK细胞细胞因子产生和中性粒细胞吞噬作用增加,尤其是对新变种。怀孕增加了记忆CD4+T细胞、IFNγ产生、单功能优势和脂肪酸氧化。怀孕可能会降低体液免疫和细胞免疫的广度、组成和强度,尤其是对新变种的反应。

相似文献

1
Pregnancy reduces COVID-19 vaccine immunity against novel variants.怀孕会降低新冠疫苗对新型变体的免疫力。
NPJ Vaccines. 2025 Aug 13;10(1):191. doi: 10.1038/s41541-025-01236-4.
2
Pregnancy Reduces COVID-19 Vaccine Immunity Against Novel Variants.怀孕会降低新冠疫苗对新变种的免疫力。
medRxiv. 2025 Apr 10:2025.01.29.25321357. doi: 10.1101/2025.01.29.25321357.
3
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis.人类单克隆抗体对XBB.1.5新冠单价疫苗反应的图谱绘制:一项B细胞分析
Lancet Microbe. 2025 May 30:101103. doi: 10.1016/j.lanmic.2025.101103.
4
COVID-19 Vaccines2019冠状病毒病疫苗
5
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.
6
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.一种编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎XBB.1.5受体结合结构域的信使核糖核酸(mRNA)疫苗可保护小鼠免受JN.1变体的感染。
EBioMedicine. 2025 Jun 6;117:105794. doi: 10.1016/j.ebiom.2025.105794.
7
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history.具有不同疫苗接种史的小鼠中,单价和多价亚单位疫苗针对新冠病毒变异株的免疫原性。
Microbiol Spectr. 2025 Jul 17:e0290724. doi: 10.1128/spectrum.02907-24.
8
Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5-80 years in India: a phase 3, single-blind, randomised controlled trial.印度5至80岁人群中XBB.1.5 RBD亚单位新冠疫苗加强剂量的安全性和免疫原性:一项3期、单盲、随机对照试验
Lancet Reg Health Southeast Asia. 2025 Jul 24;40:100642. doi: 10.1016/j.lansea.2025.100642. eCollection 2025 Sep.
9
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
10
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort.COVID-19 mRNA疫苗接种在接种者和突破性感染个体中引发的黏膜和血清中和免疫反应:来自路易斯维尔队列的纵向研究
Vaccines (Basel). 2025 May 24;13(6):559. doi: 10.3390/vaccines13060559.

引用本文的文献

1
Mucosal immunity and vaccination strategies: current insights and future perspectives.黏膜免疫与疫苗接种策略:当前见解与未来展望。
Mol Biomed. 2025 Aug 20;6(1):57. doi: 10.1186/s43556-025-00301-7.

本文引用的文献

1
Short-lived neutralizing activity against SARS-CoV-2 in newborns of immunized mothers.免疫母亲的新生儿体内针对新冠病毒的短期中和活性。
Pediatr Allergy Immunol. 2025 Apr;36(4):e70084. doi: 10.1111/pai.70084.
2
Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons.孕期新冠疫苗的免疫原性:孕妇与非孕妇的系统评价及比较
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S27-S31. doi: 10.1097/INF.0000000000004633. Epub 2025 Feb 14.
3
Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG.
比较 COVID-19 感染和疫苗接种在孕妇中诱导的抗-S IgG 免疫原性。
BMC Infect Dis. 2024 Sep 9;24(1):935. doi: 10.1186/s12879-024-09853-5.
4
A prospective cohort study of pregnancy outcomes following antepartum infection with SARS-CoV-2.一项关于 SARS-CoV-2 产前感染后妊娠结局的前瞻性队列研究。
Pregnancy Hypertens. 2024 Sep;37:101152. doi: 10.1016/j.preghy.2024.101152. Epub 2024 Aug 29.
5
The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies.不断出现的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)JN.1变体:进化、传染性、免疫逃逸及应对策略
MedComm (2020). 2024 Jul 29;5(8):e675. doi: 10.1002/mco2.675. eCollection 2024 Aug.
6
SARS-CoV-2 correlates of protection from infection against variants of concern.SARS-CoV-2 对感染关切变异株的保护相关因素。
Nat Med. 2024 Oct;30(10):2805-2812. doi: 10.1038/s41591-024-03131-2. Epub 2024 Jul 26.
7
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies.保护性非中和性 SARS-CoV-2 单克隆抗体。
Trends Immunol. 2024 Aug;45(8):609-624. doi: 10.1016/j.it.2024.06.003. Epub 2024 Jul 20.
8
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons.一项关于全球孕妇对新冠疫苗犹豫情况的范围综述。
NPJ Vaccines. 2024 Jul 20;9(1):131. doi: 10.1038/s41541-024-00913-0.
9
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus.新冠病毒疫苗接种两年后出现的高浓度抗SARS-CoV-2抗体不仅源于加强针,还源于广泛的、通常未被识别的与病毒的接触。
Vaccines (Basel). 2024 Apr 28;12(5):471. doi: 10.3390/vaccines12050471.
10
Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study.妊娠合并 COVID-19 患者住院后的围产结局:一项英国全国队列研究。
Nat Commun. 2024 Apr 15;15(1):3234. doi: 10.1038/s41467-024-47181-z.